Skip to main content

NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022.

Publication ,  Journal Article
Caudell, JJ; Gillison, ML; Maghami, E; Spencer, S; Pfister, DG; Adkins, D; Birkeland, AC; Brizel, DM; Busse, PM; Cmelak, AJ; Colevas, AD ...
Published in: J Natl Compr Canc Netw
March 2022

The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity (including mucosal lip), pharynx, larynx, and paranasal sinuses. Occult primary cancer, salivary gland cancer, and mucosal melanoma (MM) are also addressed. The specific site of disease, stage, and pathologic findings guide treatment (eg, the appropriate surgical procedure, radiation targets, dose and fractionation of radiation, indications for systemic therapy). The NCCN Head and Neck Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's most recent recommendations regarding management of HPV-positive oropharynx cancer and ongoing research in this area.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

March 2022

Volume

20

Issue

3

Start / End Page

224 / 234

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Humans
  • Head and Neck Neoplasms
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Caudell, J. J., Gillison, M. L., Maghami, E., Spencer, S., Pfister, D. G., Adkins, D., … Darlow, S. D. (2022). NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022. J Natl Compr Canc Netw, 20(3), 224–234. https://doi.org/10.6004/jnccn.2022.0016
Caudell, Jimmy J., Maura L. Gillison, Ellie Maghami, Sharon Spencer, David G. Pfister, Douglas Adkins, Andrew C. Birkeland, et al. “NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022.J Natl Compr Canc Netw 20, no. 3 (March 2022): 224–34. https://doi.org/10.6004/jnccn.2022.0016.
Caudell JJ, Gillison ML, Maghami E, Spencer S, Pfister DG, Adkins D, et al. NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022. J Natl Compr Canc Netw. 2022 Mar;20(3):224–34.
Caudell, Jimmy J., et al. “NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022.J Natl Compr Canc Netw, vol. 20, no. 3, Mar. 2022, pp. 224–34. Pubmed, doi:10.6004/jnccn.2022.0016.
Caudell JJ, Gillison ML, Maghami E, Spencer S, Pfister DG, Adkins D, Birkeland AC, Brizel DM, Busse PM, Cmelak AJ, Colevas AD, Eisele DW, Galloway T, Geiger JL, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Mell LK, Mittal BB, Pinto HA, Rocco JW, Rodriguez CP, Savvides PS, Schwartz D, Shah JP, Sher D, St John M, Weber RS, Weinstein G, Worden F, Yang Bruce J, Yom SS, Zhen W, Burns JL, Darlow SD. NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022. J Natl Compr Canc Netw. 2022 Mar;20(3):224–234.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

March 2022

Volume

20

Issue

3

Start / End Page

224 / 234

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Humans
  • Head and Neck Neoplasms
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis